Clopidogrel vs Nivolumab

## Clopidogrel vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Clopidogrel** and **Nivolumab**.

## Mechanism of Action

**Clopidogrel**: Irreversibly blocks P2Y12 ADP receptor on platelets.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Clopidogrel — 6 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Clopidogrel — C16H16ClNO2S; Nivolumab — N/A.

**Molecular Weight**: Clopidogrel — 321.8220 g/mol; Nivolumab — N/A.

**Type**: Clopidogrel — Small molecule; Nivolumab — Antibody.